Hims & Hers Health had its Relative Strength (RS) Rating upgraded from 88 to 93 Wednesday.
Here Are 3 Keys For Successful Stock Investing
This exclusive rating from Investor's Business Daily identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.
History shows that the best stocks typically have an RS Rating of at least 80 at the beginning of a new price run.
While the stock is not near an ideal buy point right now, see if it is able to form and break out of a proper chart pattern.
Hims & Hers Health posted 183% EPS growth last quarter. Sales rose 73%.
The company holds the No. 3 rank among its peers in the Medical-Services industry group. GeneDx Holdings is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
